Treatment with a GLP-1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders.
Mansur RB, Zugman A, Ahmed J, Cha DS, Subramaniapillai M, Lee Y, Lovshin J, Lee JG, Lee JH, Drobinin V, Newport J, Brietzke E, Reininghaus EZ, Sim K, Vinberg M, Rasgon N, Hajek T, McIntyre RS.
Mansur RB, et al. Among authors: cha ds.
Eur Neuropsychopharmacol. 2017 Nov;27(11):1153-1162. doi: 10.1016/j.euroneuro.2017.08.433. Epub 2017 Sep 1.
Eur Neuropsychopharmacol. 2017.
PMID: 28867303